Overview

Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
Comparison of various antibiotics in treatment of uncomplicated pelvic inflammatory disease
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Fluoroquinolones
Levofloxacin
Metronidazole
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ofloxacin